Blogs
Why Weight Loss Plateaus on GLP-1 Drugs - and What It Actually Means
Many people experience weight loss plateaus while using GLP-1 medications. These plateaus are not signs that treatment has failed, but normal metabolic adaptations that often require stabilization, muscle preservation, and long-term strategy adjustments.
Read More
Muscle Loss on GLP-1 Drugs: The Hidden Risk No One Warns You About
GLP-1 medications are highly effective for appetite suppression and weight loss, but rapid calorie reduction can also lead to unintended muscle loss. Preserving lean mass is essential for maintaining metabolism, energy, and long-term weight-loss success.
Read More
GLP-1 vs GIP vs Amylin: What Patients Are Never Told
GLP-1 medications are often described as appetite suppressants, but appetite is only one part of weight regulation. Hormones like GIP and amylin also influence metabolism, satiety, and long-term energy balance—factors that are rarely explained to patients.
Read More
Why GLP-1 Drugs Alone Aren’t Enough for Sustainable Weight Loss
GLP-1 medications can drive rapid weight loss, but they rarely address the deeper metabolic factors required for long-term success. Learn why GLP-1 drugs alone often lead to muscle loss, fatigue, and weight regain—and what a sustainable, metabolism-first approach looks like.
Read More
What Is Metabolic Flexibility? The Missing Skill Modern Metabolism Has Lost
An educational exploration of metabolic flexibility, fuel utilization, insulin sensitivity, energy regulation, and why the ability to switch between carbohydrates and fat may be one of the most important components of long-term metabolic health.
Read More
Why Constant Snacking May Reduce Metabolic Flexibility
An educational exploration of how frequent eating and constant snacking may influence metabolic flexibility, fuel utilization, insulin signaling, energy stability, and long-term metabolic adaptability.
Read More